{
  "title": "Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.",
  "pmid": "40691143",
  "doi": null,
  "affiliations": [
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK. df132@le.ac.uk.",
    "Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK. df132@le.ac.uk.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Novogene Co. Limited, Beijing, China.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Center for Genomic Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Faculty of Medicine, University of Tripoli, Tripoli, Libya.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.",
    "Department of Medical Oncology, Wythenshawe Hospital, Manchester, UK.",
    "Patrick G. Johnston Centre for Cancer Research, Queens University Belfast, Northern Ireland, UK.",
    "Department of Oncology, Sheffield Teaching Hospitals NHS Foundation, Sheffield, UK.",
    "Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.",
    "Mavis Nye Foundation, c/o University of Southampton, Southampton, UK.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK.",
    "Cancer Research UK Barts Cancer Institute, Queen Mary University of London, London, UK.",
    "York Teaching Hospital NHS Foundation Trust, York, UK.",
    "Mesothelioma UK, Loughborough, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK.",
    "Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK.",
    "UWA Centre for Medical Research & Harry Perkins Institute of Medical Research, Perth, Australia.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Mesothelioma Research Programme, CRUK Experimental Cancer Centre & NIHR Biomedical Research Centre, University of Leicester, UK Robert Kilpatrick Clinical Sciences Building, Leicester, UK.",
    "Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.",
    "Singleton & Morrison Hospitals, South Wales, UK.",
    "Bioinformatics Analysis Support Hub, University of Leicester, Leicester, UK.",
    "School of Computing and Mathematical Sciences, University of Leicester, Leicester, UK.",
    "School of Computing and Mathematical Sciences, University of Leicester, Leicester, UK.",
    "School of Computing and Mathematical Sciences, University of Leicester, Leicester, UK.",
    "Thoracic Oncology Immunotherapy Group, The Institute of Cancer Research, Sutton, London, UK.",
    "Cancer Research UK Southampton Clinical Trials Unit & NIHR Southampton Biomedical Research Centre UK, University of Southampton, Southampton, UK."
  ]
}